chr14-91416785-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001080414.4(CCDC88C):c.114C>T(p.Tyr38Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.217 in 1,612,464 control chromosomes in the GnomAD database, including 41,649 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.17 ( 2774 hom., cov: 32)
Exomes 𝑓: 0.22 ( 38875 hom. )
Consequence
CCDC88C
NM_001080414.4 synonymous
NM_001080414.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.461
Genes affected
CCDC88C (HGNC:19967): (coiled-coil domain containing 88C) This gene encodes a ubiquitously expressed coiled-coil domain-containing protein that interacts with the dishevelled protein and is a negative regulator of the Wnt signalling pathway. The protein encoded by this gene has a PDZ-domain binding motif in its C-terminus with which it interacts with the dishevelled protein. Dishevelled is a scaffold protein involved in the regulation of the Wnt signaling pathway. The Wnt signaling pathway plays an important role in embryonic development, tissue maintenance, and cancer progression. Mutations in this gene cause autosomal recessive, primary non-syndromic congenital hydrocephalus; a condition characterized by excessive accumulation of cerebrospinal fluid in the ventricles of the brain. [provided by RefSeq, Jan 2013]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 14-91416785-G-A is Benign according to our data. Variant chr14-91416785-G-A is described in ClinVar as [Benign]. Clinvar id is 158090.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.461 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.245 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC88C | NM_001080414.4 | c.114C>T | p.Tyr38Tyr | synonymous_variant | Exon 2 of 30 | ENST00000389857.11 | NP_001073883.2 | |
CCDC88C | XM_011536796.3 | c.6C>T | p.Tyr2Tyr | synonymous_variant | Exon 2 of 30 | XP_011535098.1 | ||
CCDC88C | NR_189158.1 | n.244C>T | non_coding_transcript_exon_variant | Exon 2 of 31 | ||||
CCDC88C | NR_189159.1 | n.244C>T | non_coding_transcript_exon_variant | Exon 2 of 31 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.171 AC: 25993AN: 152006Hom.: 2778 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
25993
AN:
152006
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.171 AC: 42367AN: 247748 AF XY: 0.175 show subpopulations
GnomAD2 exomes
AF:
AC:
42367
AN:
247748
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.222 AC: 324461AN: 1460342Hom.: 38875 Cov.: 33 AF XY: 0.220 AC XY: 159505AN XY: 726512 show subpopulations
GnomAD4 exome
AF:
AC:
324461
AN:
1460342
Hom.:
Cov.:
33
AF XY:
AC XY:
159505
AN XY:
726512
African (AFR)
AF:
AC:
2412
AN:
33468
American (AMR)
AF:
AC:
4845
AN:
44666
Ashkenazi Jewish (ASJ)
AF:
AC:
4525
AN:
26126
East Asian (EAS)
AF:
AC:
1331
AN:
39698
South Asian (SAS)
AF:
AC:
11868
AN:
86190
European-Finnish (FIN)
AF:
AC:
8344
AN:
53290
Middle Eastern (MID)
AF:
AC:
691
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
278538
AN:
1110798
Other (OTH)
AF:
AC:
11907
AN:
60340
Heterozygous variant carriers
0
11617
23235
34852
46470
58087
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
9142
18284
27426
36568
45710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.171 AC: 25989AN: 152122Hom.: 2774 Cov.: 32 AF XY: 0.163 AC XY: 12125AN XY: 74356 show subpopulations
GnomAD4 genome
AF:
AC:
25989
AN:
152122
Hom.:
Cov.:
32
AF XY:
AC XY:
12125
AN XY:
74356
African (AFR)
AF:
AC:
3369
AN:
41492
American (AMR)
AF:
AC:
2300
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
623
AN:
3470
East Asian (EAS)
AF:
AC:
129
AN:
5178
South Asian (SAS)
AF:
AC:
626
AN:
4820
European-Finnish (FIN)
AF:
AC:
1521
AN:
10582
Middle Eastern (MID)
AF:
AC:
41
AN:
294
European-Non Finnish (NFE)
AF:
AC:
16847
AN:
67978
Other (OTH)
AF:
AC:
348
AN:
2108
Heterozygous variant carriers
0
1099
2198
3297
4396
5495
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
280
560
840
1120
1400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
263
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
Apr 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Spinocerebellar ataxia type 40 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Hydrocephalus, nonsyndromic, autosomal recessive 1 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=96/4
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at